PUK News 44.79 Prudential Public Limited Company (PUK)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prudential Public Limited Company (PUK) 44.79 $PUK

Charity has a New Beat: Prudence Foundation Teams Up with Rock Singer Arnel Pineda for Typhoon Haiyan Recovery Efforts
PR Newswire - Tue Apr 08, 8:00AM CDT
Prudence Foundation, the regional charitable arm of Prudential Corporation Asia (Prudential), has launched a new episode of the popular financial literacy animation Cha-Ching and a new version of its "Charity" song to raise funds for the Typhoon Haiyan disaster relief and recovery effort. The foundation has joined hands with renowned Filipino singer and American rock band Journey frontman, Arnel Pineda, who lends his soaring rock vocals to this innovative fund-raising initiative.

Why You Could Die Broke, Lonely and Miserable
at The Street - Mon Apr 07, 9:36AM CDT
Long-term care, and the insurance to pay for it, have broken financial models.

Jackson Promotes IRI's Annual National Retirement Planning Week April 7-11
Business Wire - Mon Apr 07, 9:29AM CDT
Jackson National Life Insurance Company(R) (Jackson(R)) has announced the company will serve as an advocate for National Retirement Planning Week(R), a national effort to help consumers focus on their financial needs in retirement. The national campaign, held April 7-11, is led by Insured Retirement Institute (IRI) and the National Retirement Planning Coalition, a group of prominent education, consumer advocacy and financial services organizations.

Private Medical Insurance in the UK 2014-2017 with Bupa, Axa, Aviva and Prudential Dominating
M2 - Thu Apr 03, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w8qpld/private_medical) has announced the addition of the "Private Medical Insurance in the UK, Key Trends and Opportunities to 2017" report to their offering. Gross written premiums in the private medical insurance category amounted to GBP3.65 billion in 2012, recording growth of 3.2% from 2011, and a compound annual growth rate (CAGR) of 2.47% during the review period (2008-2012). Favorable developments in premiums belie the underlying trends in demand, however. As a discretionary insurance product, supplementary to free-to-access healthcare through the National Health Service (NHS), the number of private medical policyholders has been subject to a downwards trend since 2006 and hit its lowest level on record in 2012, at 5.6 million. Factors driving the apparent shift in attitudes include improved levels of satisfaction with the NHS, increased public healthcare spending, and deterioration in labor market conditions. The market for private medical insurance is dominated by four insurers - Bupa, Axa, Aviva and Prudential - which have a combined market share of 92%. Despite this concentrated market, a lack of competition between private hospital operators has restricted insurers' bargaining power and resulted in inflated claims costs. Coupled with the decline in customer numbers, this has been the biggest driver of premium growth as insurers responded to drags on profitability by raising prices for customers. The consumer shift away from private medical insurance is unlikely to be fully reversed. Nevertheless, favorable forces will underpin a modest CAGR of 2% for gross written premiums over the forecast period (2013-2017). A recovery in economic growth will improve wage and employment conditions, NHS reforms are expected to advance the role of the private healthcare and insurance sector, while the UK's evolving demographic profile will increase the strain on the public healthcare system. Improving economic conditions do not prescribe continued growth in the category, however, as the recession-induced demand for lower-cost policy coverage has spurred an increase in the popularity and availability of cheaper healthcare cash plans and self-pay options for one-off treatments. This new market dynamic threatens to divert customers away from comprehensive, but high-premium private medical insurance policies. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Porter's Five Forces Analysis 6 Deals 7 News 8 Regulation and Compliance 9 Macroeconomic Backdrop 10 Company Profiles 11 Statistics 12 Appendix Companies Mentioned - Aviva Plc - Axa UK Plc - Bupa Insurance Ltd - Chubb Insurance Company of Europe SE - Cigna Life Insurance Company of Europe SA-NV - Exeter Friendly Society Ltd - Great Lakes Reinsurance (UK) Plc - Prudential Plc - Simplyhealth Group Ltd - Western Provident Association For more information visit http://www.researchandmarkets.com/research/w8...te_medical

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: PUK, BBVA, VMI
at The Street - Tue Mar 25, 9:00AM CDT
PUK BBVA VMI are going ex-dividend tomorrow, Wednesday, March 26, 2014, 4:00 AM ET

Jackson Reports 2013 Results; Continuing to Build on Strength and Discipline
Business Wire - Wed Mar 12, 8:05AM CDT
--Record total sales and deposits(2) of $27.3 billion, an increase of 7.3% over year-end 2012

Jackson Customer Service Achieves "Call Center World Class Call Certification" for 2013
Business Wire - Thu Mar 06, 7:01AM CST
The Service Quality Measurement Group, Inc. (SQM) has again awarded Jackson National Life Insurance Company(R) (Jackson(R)) with "Call Center World Class Call Certification" for 2013. Jackson also received the "Highest Customer Service by Industry" award, achieving the top rating for the financial industry.(1) The awards mark the ninth year Jackson has been recognized for its customer service performance in both of these categories.(2)

Upgrade Alert for Prudential (PUK)
Comtex SmarTrend(R) - Mon Mar 03, 7:01AM CST
Prudential (NYSE UK) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $45.40 on volume of 187,000 shares, below average daily volume of 241,000. In the past 52 weeks, Prudential share prices have been bracketed by a low of $29.69 and a high of $46.16 and closed yesterday at $45.40, 53% above that low price. The 200-day and 50-day moving averages have moved 0.60% higher and 0.84% higher over the past week, respectively.

Prudential (PUK) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 9:06AM CST
Prudential (PUK) Sees Hammer Chart Pattern: Time to Buy?

Jackson's Alternative Investments Education Campaign Reached Thousands of Advisors in 2013, Plans to Expand in 2014
Business Wire - Thu Feb 06, 10:40AM CST
Jackson National Life Insurance Company(R) (Jackson(R)) will expand its extensive alternative investments educational opportunities for advisors throughout 2014 with a dedicated focus on helping advisors understand and implement alternative asset classes into client portfolios. Over the past year, Jackson has successfully reached more than 10,000 advisors across the industry through hundreds of seminars, webcasts and training programs, as well as through robust multimedia marketing materials focused on alternative investments.

Old Republic Beats on Q4 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 24, 5:03PM CST
Old Republic reported its fourth-quarter 2013 operating net income of 33 cents per share, which outpaced the Zacks Consensus Estimate by 83.3%.


Cameron, Bono link poverty, climate at AP debate
By JOHN HEILPRIN - AP - Fri Jan 24, 2:07PM CST
DAVOS, Switzerland (AP) — Global leaders argued Friday that efforts to eradicate poverty must be linked to climate change, saying that rising temperatures will have widespread effects on everything from food supplies to education.

AEGON Proposes Accounting Changes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 4:30PM CST
AEGON N.V. recently announced that it has made certain changes to its accounting policies associated with deferred policy acquisition costs and longevity reserves

Assurant Expands in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 3:55PM CST
Assurant Inc. agreed to make $115 million worth of equity investment in Latin American services assistance provider Ike Asistencia.

Marsh & McLennan Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 2:40PM CST
Riding on a steady growth momentum, shares of Marsh & McLennan Cos. (MMC) hit a new 52-week high of $48.83 on Jan 21.

FBL Financial Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 5:20PM CST
On Jan 21, Zacks Investment Research upgraded FBL Financial Group Inc. by a notch to a Zacks Rank #1 (Strong Buy).

26.0% Return Seen to Date on SmarTrend Prudential Call (PUK)
Comtex SmarTrend(R) - Fri Jan 17, 5:02PM CST
SmarTrend identified an Uptrend for Prudential (NYSE UK) on September 9th, 2013 at $35.86. In approximately 4 months, Prudential has returned 26.05% as of today's recent price of $45.20.

Arthur J. Gallagher & Co. Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 17, 3:10PM CST
On Jan 16, 2014, shares of Arthur J. Gallagher & Co. touched a new 52-week high of $48.79

AIG Launches Financial Network - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 6:20PM CST
American International's share price has been on an uptrend since the onset of the fourth quarter, reflecting investors' enthusiasm about its developments so far

Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading